Related Experiment Videos
Life-threatening hypercalcemia complicated by pancreatitis in a child with acute lymphoblastic leukemia
Elpis Mantadakis1, Nicole Anagnostatou, Penelope Smyrnaki
1Department of Pediatric Hematology/Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece.
Insights
Severe hypercalcemia in a child with precursor-B acute lymphoblastic leukemia (ALL) required intensive care. Prompt treatment of ALL and supportive care resolved the life-threatening complication.
Area of Science:
- Pediatric Oncology
- Pediatric Hematology
- Pediatric Critical Care Medicine
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Metabolic complications, such as hypercalcemia, can occur in children with ALL.
- Hypercalcemia is an uncommon but potentially life-threatening complication in pediatric ALL.
Observation:
- A 9-year-old girl with precursor-B ALL presented with severe hypercalcemia and dehydration.
- She had received recent oral vitamin D and calcium supplementation.
- Hospitalization in a pediatric intensive care unit (PICU) was required for management.
Findings:
- The patient developed pancreatitis, disseminated intravascular coagulation, pleural effusion, and seizures.
- Hypercalcemia was likely multifactorial, related to ALL and possibly supplementation.
- Hypercalcemia resolved with chemotherapy, supportive care, and calcitonin.
Implications:
- This case highlights the importance of recognizing and managing hypercalcemia in pediatric ALL.
- Prompt diagnosis and multidisciplinary care are crucial for managing severe metabolic complications.
- Referral to tertiary-care centers with PICU and subspecialty support is recommended for children with ALL.
Abstract:
The authors describe a 9-year-old girl with precursor-B acute lymphoblastic leukemia (ALL) who presented with dehydration and severe hypercalcemia. She had received oral vitamin D and calcium supplementation for 4 days, the last dose 48 hours prior to admission, and required pediatric intensive care unit (PICU) hospitalization for management of the hypercalcemia and safe initiation of induction chemotherapy. Her clinical course was complicated by pancreatitis, disseminated intravascular coagulation, pleural effusion, and focal seizures. Although the exact mechanism of hypercalcemia was not elucidated, it was likely related to the underlying ALL, without dismissing the prior vitamin D and calcium supplementation as a possible contributing factor. The hypercalcemia resolved with specific antileukemic therapy along with supportive care and administration of calcitonin. Hypercalcemia is an uncommon metabolic abnormality in children with ALL, but it can be life-threatening. Children with ALL should be referred to tertiary-care institutions with PICU and subspecialty support because serious metabolic and other complications can occur before or after the administration of chemotherapy.
Related Concept Videos
Acute Pancreatitis II: Pathophysiology
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction